The burgeoning landscape of novel treatments for weight management has seen the rise of both retatrutide and tirzepatide, both dual mechanism agonists targeting the GLP-1 and GIP receptors. While sharing a alike https://philipejxo134009.wikiexcerpt.com/4137180/retatrutide_vs_tirzepatide_a_comparative_analysis